🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Colonic Neoplasms Malignant

AI-Assisted Chemotherapy Side Effect Management NCT07198581NA1 site📍 Incheon Incheon St.Mary's Hospital · Tests: LLM-assisted chemotherapy side effect management Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers NCT02584244Phase 1, Phase 21 site📍 Boston Lumicell, Inc. · Tests: LUM015, LUM 2.6 Imaging Device COLON-IM : Microbiota and Immune Infiltrate in Normal, Dysplastic and Neoplastic Colorectal Tissue NCT03841799n/a3 sites📍 Lyon📍 Lyon📍 Lyon Centre Leon Berard Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors NCT04557449Phase 1, Phase 239 sites📍 Los Angeles📍 New Haven📍 New Haven Pfizer · Tests: PF-07220060, Letrozole, Fulvestrant, Midazolam, Enzalutamide DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer NCT06275958Phase 336 sites📍 's-Hertogenbosch📍 Alkmaar📍 Amstelveen Leiden University Medical Center · Tests: Doublet Chemotherapy, Standard Dose (100%), Doublet Chemotherapy, Dose-reduced (75%), Monotherapy, Standard Dose (100%)… A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies NCT04678648Phase 13 sites📍 Los Angeles📍 Denver📍 Nashville RasCal Therapeutics, Inc. · Tests: RSC-1255 Dose Escalation, RSC-1255 Dose Expansion Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer NCT06307548Phase 1, Phase 21 site📍 Buffalo Roswell Park Cancer Institute · Tests: Aminolevulinic Acid, Biospecimen Collection, Computed Tomography, Fluorescence-Guided Surgery, Magnetic Resonance Imagi… Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer NCT05789433NA1 site📍 Orlando AdventHealth Translational Research Institute · Tests: Aerobic exercise, Progressive stretching Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors NCT07095517Phase 11 site📍 Boston Massachusetts General Hospital · Tests: Tirzepatide ALFAOMEGA Master Observational Trial NCT04120935n/a19 sites📍 Biella📍 Milan📍 Milan IFOM ETS - The AIRC Institute of Molecular Oncology · Tests: Observation Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery NCT06349590Phase 1, Phase 21 site📍 Chicago University of Chicago · Tests: High-fiber/low-fat meals Clinical Study of Radical Right Hemicolectomy Versus Radical Right Hemicolectomy Combined with Indocyanine Green Fluorescence Imaging Lymphatic Tracer Dissection for the Treatment of Right Colon Cancer NCT06485609NA1 site📍 Guangzhou Sun Yat-sen University · Tests: radical right hemicolectomy combined with indocyanine green fluorescence imaging lymphatic tracer dissection Colorectal Cancer Real-world Outcomes Study of Survival With Immunomodulator Plus Standard Anti-cancer Therapies NCT07703709n/a1 site📍 Taichung Chou-Chen Chen Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors NCT04222413Phase 12 sites📍 Fairway📍 Bethesda National Cancer Institute (NCI) · Tests: Metarrestin Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC NCT07500259n/a1 site📍 Luxembourg Luxembourg Institute of Health · Tests: Personalized Functional Profiling Sacituzumab Govitecan in Metastatic Colorectal Cancer NCT06243393Phase 2, Phase 31 site📍 Heidelberg University Hospital Heidelberg · Tests: Sacituzumab Govitecan (SG), Physicians Choice (PhC). Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study NCT06719206NA2 sites📍 Uppsala📍 Västerås Mälardalen University · Tests: Digital self-management program Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy NCT06107920Phase 328 sites📍 Amiens📍 Beauvais📍 Besançon University Hospital, Rouen · Tests: Neoadjuvant chemotherapy A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI NCT07543744Phase 126 sites📍 Arkhangelsk📍 Istra📍 Ivanovo R-Pharm · Tests: RPH-030, Vectibix®, Irinotecan, Calcium Folinate, Fluorouracil Pre-therapeutic MRI Assessment of Early-Stage Rectal Cancer and Significant Rectal Polyps to Avoid Major Resectional Surgery NCT04103372NA23 sites📍 Reading📍 Amersham📍 London Imperial College London · Tests: MRI scan, Radiologist training CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Devimistat, Fluorouracil, Gemcitabine Hydrochloride ROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer" NCT07381764Phase 226 sites📍 Alessandria📍 Ancona📍 Aviano Gruppo Oncologico Italia Meridionale · Tests: Erbitux (Cetuximab), Bevacizumab, Irinotecan, Trifluridine/tipiracil Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites📍 Scottsdale📍 La Jolla📍 Stanford BioEclipse Therapeutics · Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide Novel Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer NCT07759921NA1 site📍 Aurora University of Colorado, Denver · Tests: Couple-based Mindfulness Intervention, Health and Wellness Education Control Condition Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients NCT07114627n/a1 site📍 Rotterdam Erasmus Medical Center · Tests: Blood sampling for pharmacokinetics Evaluation of a Diagnostic Test to Identify the Best Drugs for Treatment of Metastatic Colorectal Cancer NCT07171554NA1 site📍 Lørenskog Oncosyne AS · Tests: µCAN drug screen test, Standard-of-Care Therapy Explore Biomarkers Associated With Prognosis of Recurrent and Metastatic CRC After Surgery by Multi-omics Methods NCT05501353n/a1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: no intervention TT-702 in Patients With Advanced Solid Tumours. NCT05272709Phase 1, Phase 23 sites📍 London📍 Manchester📍 Southampton Cancer Research UK · Tests: TT-702, Anti-PD-1 and PD-L1 agent A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer NCT07284849Phase 3293 sites📍 Mobile📍 Tucson📍 Tucson Incyte Corporation · Tests: INCA33890, Placebo, Bevacizumab, FOLFOX Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC NCT06643793Phase 21 site📍 Nanjing Affiliated Hospital of Nantong University · Tests: Irinotecan liposome (ll) + 5-FU/LV + bevacizumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy